![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/CAMLINFINE.png)
Share the post "Camlin Fine Sciences ‘s Q3 2024-25 Latest News: Profit Grows by 47.69% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 12.34 % in the past year, substantial increase in net sales/revenue by 2.49 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -19.71 %, Marginal increase in other income during this quarter, up by 100.96%. 🔹 Profit over the Year and quarter: Challenges in sustaining profitability for Camlin Fine Sciences Limited. Profit dropped by -47.66 % Year to Year, Camlin Fine Sciences Limited’s profitability dropped by -93.56 % Quarter to Quarter. 🔹 EPS over the Year and quarter: EPS declined by -66.20 % Year to Year. EPS decreased by -95.99 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 385.886 Cr | Rs. 422.972 Cr | Rs. 433.49 Cr | + 2.49 % | + 12.34 % |
| Expenses | Rs. 362.56 Cr | Rs. 379.73 Cr | Rs. 386.56 Cr | + 1.8 % | + 6.62 % |
| Operating Profit | Rs. 23.33 Cr | Rs. 43.24 Cr | Rs. 46.93 Cr | + 8.53 % | + 101.16 % |
| OPM % | 6.05 % | 10.22 % | 10.83 % | + 0.61 % | + 4.78 % |
| Other Income | Rs. 1.664 Cr | Rs. -138.942 Cr | Rs. 1.336 Cr | + 100.96 % | -19.71 % |
| Interest | Rs. 14.14 Cr | Rs. 26.42 Cr | Rs. 34.12 Cr | + 29.14 % | + 141.3 % |
| Depreciation | Rs. 20.58 Cr | Rs. 20.69 Cr | Rs. 14.48 Cr | -30.01 % | -29.64 % |
| Profit before tax | Rs. -9.73 Cr | Rs. -142.81 Cr | Rs. -0.33 Cr | + 99.77 % | + 96.61 % |
| Tax % | -46.73 % | -18.35 % | 469.38 % | + 487.73 % | + 516.11 % |
| Net Profit | Rs. -14.28 Cr | Rs. -116.11 Cr | Rs. -7.47 Cr | + 93.57 % | + 47.69 % |
| EPS in Rs | Rs. -0.7 | Rs. -5.93 | Rs. -0.24 | + 95.95 % | + 65.71 % |
Today, we’re looking at Camlin Fine Sciences Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 12.34 %. However, it did see a marginal increase of 2.49 % from the previous quarter. Expenses ticked up slightly by 1.8 % quarter-on-quarter, aligning with the annual rise of 6.62 %. Operating profit, while up 101.16 % compared to last year, faced a quarter-on-quarter increase of 8.53 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 4.78 %, but an expansion of 0.61 % sequentially. Other income rose by 100.96 % compared to the last quarter, despite an annual decline of -19.71 %. Interest expenses surged remarkably by 29.14 % from the previous quarter, yet the year-over-year increase remains at a moderate 141.3 %. Depreciation costs fell by -30.01 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -29.64 %. Profit before tax grew annually by 96.61 % but saw an increase from the preceding quarter by 99.77 %.
Tax expenses as a percentage of profits increased slightly by 516.11 % compared to last year, with a more notable quarter-on-quarter increase of 487.73 %. Net profit rose by 47.69 % year-on-year but experienced a 93.57 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 65.71 % but a quarterly rise of 95.95 %. In summary, Camlin Fine Sciences Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 385.886 Cr | Rs. 422.972 Cr | Rs. 433.49 Cr | + 2.49 % | + 12.34 % |
| Expenses | Rs. 362.56 Cr | Rs. 379.73 Cr | Rs. 386.56 Cr | + 1.8 % | + 6.62 % |
| Operating Profit | Rs. 23.33 Cr | Rs. 43.24 Cr | Rs. 46.93 Cr | + 8.53 % | + 101.16 % |
| Net Profit | Rs. -14.28 Cr | Rs. -116.11 Cr | Rs. -7.47 Cr | + 93.57 % | + 47.69 % |
| EPS in Rs | Rs. -0.7 | Rs. -5.93 | Rs. -0.24 | + 95.95 % | + 65.71 % |
In reviewing Camlin Fine Sciences Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 12.34 % year-on-year growth, however, there was a minor increase of 2.49 % from the previous quarter. Expenses rose by 6.62 % compared to the previous year, with a 1.8 % increase quarter-on-quarter. Operating Profit surged by 101.16 % annually, and saw a 8.53 % increase from the last quarter.
Net Profit showed yearly increase of 47.69 %, and experienced a 93.57 % increase from the previous quarter. Earnings Per Share (EPS) rose by 65.71 % annually, however rose by 95.95 % compared to the last quarter. In essence, while Camlin Fine Sciences Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/shareholding/stock-market-digital-board-s4wrcgzaoi75zh4h.jpg)
